|
NUMB expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.60524934958539E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.8700996307075E-10 |
| Normal-vs-Stage2 |
5.211100E-04 |
| Normal-vs-Stage3 |
1.36779476633819E-13 |
| Normal-vs-Stage4 |
1.64801505775358E-12 |
| Stage1-vs-Stage2 |
1.783570E-01 |
| Stage1-vs-Stage3 |
6.015200E-03 |
| Stage1-vs-Stage4 |
6.381500E-04 |
| Stage2-vs-Stage3 |
3.856300E-03 |
| Stage2-vs-Stage4 |
5.643200E-04 |
| Stage3-vs-Stage4 |
2.293400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.40438829641244E-14 |
| Normal-vs-AfricanAmerican |
7.53140000031571E-07 |
| Normal-vs-Asian |
1.82240000001777E-06 |
| Caucasian-vs-AfricanAmerican |
9.731400E-01 |
| Caucasian-vs-Asian |
1.619380E-01 |
| AfricanAmerican-vs-Asian |
3.814600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.8297033039546E-11 |
| Normal-vs-Female |
6.79323264307641E-12 |
| Male-vs-Female |
6.919600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.74480002562905E-10 |
| Normal-vs-Age(41-60Yrs) |
6.38100683403309E-12 |
| Normal-vs-Age(61-80Yrs) |
2.00461869326318E-12 |
| Normal-vs-Age(81-100Yrs) |
2.768200E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.717400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.959800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.273600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.468600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.277000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.619000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.60737000000077E-05 |
| Classical-VS-Follicular |
5.862500E-03 |
| Classical-VS-Other |
5.815000E-01 |
| Classical-VS-Normal |
2.31115127036219E-12 |
| Tall-VS-Follicular |
2.5053999985758E-08 |
| Tall-VS-Other |
1.057640E-01 |
| Tall-VS-Normal |
1.63802305053196E-12 |
| Follicular-VS-Other |
1.910190E-01 |
| Follicular-VS-Normal |
4.010000E-04 |
| Other-VS-Normal |
5.395500E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.61279997637587E-10 |
| Normal-vs-N1 |
4.9972026516798E-11 |
| N0-vs-N1 |
3.506100E-02 |
|
|
